Pfizer Declares Second-Quarter 2025 DividendApr. 23BU Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual MeetingApr. 23BU Pfizer : Political Action Committee (PAC) Report January 2023 - December 2024Apr. 21PU
Microsoft Corporation Common Stock $456.24 -2.62-0.57% Trending ETFs Data as of May 20, 2025 11:31 AM ET QQQ Invesco Qqq Trust, Series 1 $519.75 -2.26-0.43% SPY Spdr S&P 500 $593.47 -1.38-0.23% SCHD Schwab Us Dividend Equity Etf ...
Dividend Calendar Economic Calendar IPO Calendar Stock Splits Stock Buybacks Market Holidays Dividends Dividend Center Best Dividend Stocks Popular Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison New Dividend Calculator Dividend Returns Comparison Dividend Calendar Experts Top Analy...
Pfizer Inc PFE:NYSE EXPORT WATCHLIST+ RT Quote | Last NASDAQ LS, VOL From CTA | USD After Hours: Last | 6:06 AM EDT 23.81-0.06 (-0.25%) Volume 22,118 Close 23.87-0.33 (-1.36%) Volume 36,848,268 52 week range 20.92 - 31.54...
Dividend Yield (TTM) 6.57% Annual Payout (TTM) $0.78 Payout Ratio - 5 Year Growth Rate (CAGR) - Years of Growth 2 Years Latest Announced Dividend $0.20 Ex-Dividend Date 1/24/2025 Payout Date 3/14/2025 Frequency Quarterly More On Dividends » PFE:CA Dividend Growth History More On ...
stoxline.com provides: stock quote, technical analysis, fundamental analysis, stock rating, stock news
52 Week Low Date04/09/25 Market Cap130.991B Shares Out5.69B 10 Day Average Volume49.93M Dividend1.72 Dividend Yield7.47% Beta0.53 YTD % Change-13.15 RATIOS/PROFITABILITY EPS (TTM)1.38 P/E (TTM)16.71 Fwd P/E (NTM)8.25 EBITDA (TTM)23.837B ...
Pfizer Pflash: A Spotlight on IRA Part D Redesign and its Impact in 2025 Presentation(opens in new window) Transcript(opens in new window) Webcast(opens in new window) 03.03.2025 TD Cowen 45th Annual Health Care Conference Transcript(opens in new window) ...
Stock Quote Stock Chart Historical Stock Quote Investment Calculator Dividend & Split History Stock FAQs Corporate Governance Corporate Governance Overview Board of Directors Board Committees & Charters Corporate Governance Documents Board Policies Corporate Governance FAQs Contact Our Directors More Resources Sh...
dividend, invested $5.2 billion in internal R&D and as expected, the completed business development activity was minimal. Our commitment to delevering our capital structure to a gross leverage target of 3.25 times remains a key priority. In support of that goal, year-to-date, we have paid ...